Efficacy and Safety of Dasotraline in Adults With Binge-Eating Disorder: A Randomized, Placebo-Controlled, Flexible-Dose Clinical Trial.
Author | |
---|---|
Abstract | :
Binge-eating disorder (BED) is the most prevalent eating disorder; however, few evidence-based treatments are available. The aim of this study was to evaluate the efficacy and safety of dasotraline, a novel dopamine and norepinephrine reuptake inhibitor, in adults with BED. |
Year of Publication | :
2020
|
Journal | :
The Journal of clinical psychiatry
|
Volume | :
81
|
Issue | :
5
|
Date Published | :
2020
|
ISSN Number | :
0160-6689
|
URL | :
http://www.psychiatrist.com/JCP/article/Pages/efficacy-and-safety-of-dasotraline-in-adults-with-binge-eating-disorder.aspx
|
DOI | :
10.4088/JCP.19m13068
|
Short Title | :
J Clin Psychiatry
|
Download citation |